Aditxt (ADTX) Competitors $1.74 -0.08 (-4.40%) Closing price 05/21/2025 04:00 PM EasternExtended Trading$1.72 -0.02 (-1.15%) As of 05/21/2025 07:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ADTX vs. KRBP, VRPX, CAPS, TFFP, VINC, TCBP, BON, PTPI, NCNA, and UPCShould you be buying Aditxt stock or one of its competitors? The main competitors of Aditxt include Kiromic BioPharma (KRBP), Virpax Pharmaceuticals (VRPX), Capstone (CAPS), TFF Pharmaceuticals (TFFP), Vincerx Pharma (VINC), TC Biopharm (TCBP), Bon Natural Life (BON), Petros Pharmaceuticals (PTPI), NuCana (NCNA), and Universe Pharmaceuticals (UPC). These companies are all part of the "pharmaceutical products" industry. Aditxt vs. Kiromic BioPharma Virpax Pharmaceuticals Capstone TFF Pharmaceuticals Vincerx Pharma TC Biopharm Bon Natural Life Petros Pharmaceuticals NuCana Universe Pharmaceuticals Kiromic BioPharma (NASDAQ:KRBP) and Aditxt (NASDAQ:ADTX) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, analyst recommendations, dividends, valuation, risk, community ranking, profitability, institutional ownership and media sentiment. Which has higher valuation and earnings, KRBP or ADTX? Kiromic BioPharma has higher earnings, but lower revenue than Aditxt. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioKiromic BioPharmaN/AN/A-$26.90M-$3.50N/AAditxt$133.99K0.74-$32.38MN/AN/A Which has more risk & volatility, KRBP or ADTX? Kiromic BioPharma has a beta of 1.66, meaning that its stock price is 66% more volatile than the S&P 500. Comparatively, Aditxt has a beta of 1.6, meaning that its stock price is 60% more volatile than the S&P 500. Does the media refer more to KRBP or ADTX? In the previous week, Aditxt had 6 more articles in the media than Kiromic BioPharma. MarketBeat recorded 6 mentions for Aditxt and 0 mentions for Kiromic BioPharma. Aditxt's average media sentiment score of 1.52 beat Kiromic BioPharma's score of 0.00 indicating that Aditxt is being referred to more favorably in the news media. Company Overall Sentiment Kiromic BioPharma Neutral Aditxt Very Positive Do institutionals & insiders believe in KRBP or ADTX? 10.9% of Kiromic BioPharma shares are owned by institutional investors. Comparatively, 15.5% of Aditxt shares are owned by institutional investors. 20.6% of Kiromic BioPharma shares are owned by company insiders. Comparatively, 0.0% of Aditxt shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Is KRBP or ADTX more profitable? Kiromic BioPharma's return on equity of 0.00% beat Aditxt's return on equity.Company Net Margins Return on Equity Return on Assets Kiromic BioPharmaN/A N/A -277.46% Aditxt N/A -439.07%-122.96% Does the MarketBeat Community prefer KRBP or ADTX? Aditxt received 3 more outperform votes than Kiromic BioPharma when rated by MarketBeat users. However, 50.00% of users gave Kiromic BioPharma an outperform vote while only 44.44% of users gave Aditxt an outperform vote. CompanyUnderperformOutperformKiromic BioPharmaOutperform Votes150.00% Underperform Votes150.00% AditxtOutperform Votes444.44% Underperform Votes555.56% SummaryAditxt beats Kiromic BioPharma on 6 of the 11 factors compared between the two stocks. Get Aditxt News Delivered to You Automatically Sign up to receive the latest news and ratings for ADTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ADTX vs. The Competition Export to ExcelMetricAditxtPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$99,000.00$6.52B$5.37B$8.39BDividend YieldN/A2.65%5.22%4.10%P/E RatioN/A8.9226.8419.71Price / Sales0.74253.80392.34117.39Price / CashN/A65.8538.2534.62Price / Book0.006.466.794.50Net Income-$32.38M$143.98M$3.23B$248.18M7 Day Performance4.82%3.04%4.07%1.14%1 Month Performance-21.97%7.44%12.52%15.20%1 Year Performance-99.99%-2.46%16.83%6.56% Aditxt Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ADTXAditxt0.8663 of 5 stars$1.74-4.4%N/A-100.0%$99,000.00$133,985.000.0060Positive NewsEarnings ReportKRBPKiromic BioPharmaN/AN/AN/AN/A$330,000.00N/A-0.0660Gap DownHigh Trading VolumeVRPXVirpax Pharmaceuticals0.8885 of 5 stars$0.25+0.8%$75.00+30,512.2%-98.8%$304,000.00N/A0.007Gap UpCAPSCapstoneN/A$1.92+9.7%N/AN/A$303,000.00$44.88M0.0038Positive NewsGap DownTFFPTFF PharmaceuticalsN/A$0.07flatN/AN/A$289,000.00$-70,983.00-0.0119VINCVincerx Pharma2.4348 of 5 stars$0.06+4.4%$40.00+72,627.3%-99.7%$288,000.00N/A0.0060TCBPTC Biopharm1.2161 of 5 stars$0.68-55.8%$48.00+6,948.5%-99.6%$279,000.00$4.76M0.0080High Trading VolumeBONBon Natural LifeN/A$0.06+11.5%N/A-98.0%$259,000.00$23.84M0.00100Gap UpHigh Trading VolumePTPIPetros Pharmaceuticals0.7694 of 5 stars$0.12-0.5%N/A-99.6%$256,000.00$5.11M-0.0320News CoverageEarnings ReportGap UpHigh Trading VolumeNCNANuCana2.2106 of 5 stars$0.04-4.8%$25.00+62,400.0%-98.9%$227,000.00N/A0.0030Gap DownHigh Trading VolumeUPCUniverse PharmaceuticalsN/A$4.43-9.2%N/A-99.6%$190,000.00$23.02M0.00220High Trading Volume Related Companies and Tools Related Companies Kiromic BioPharma Alternatives Virpax Pharmaceuticals Alternatives Capstone Alternatives TFF Pharmaceuticals Alternatives Vincerx Pharma Alternatives TC Biopharm Alternatives Bon Natural Life Alternatives Petros Pharmaceuticals Alternatives NuCana Alternatives Universe Pharmaceuticals Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ADTX) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersWarning: Prepare to Be Shocked by These PayoutsThere's a strategy out there paying up to 70% on tech stocks like Amazon, Tesla, and Microsoft—stocks that don...Investors Alley | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredTrump’s treachery I think Trump’s Treasury Secretary is destroying the stock market on purpose. And no one on Wall Street see...Porter & Company | Sponsored🚨 Nvidia Just Inked a $7B AI Deal—This Could Change EverythingOn Wednesday, Nvidia stock surged—again. Why? Because Saudi Arabia just announced a multi-billion-dollar AI...Timothy Sykes | SponsoredSilver Is the New Oil—And the World’s Running DryElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aditxt, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aditxt With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ADTX Stock Free ADTX Stock Alerts